Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

• Samuel Bitoun,
• Xavier Mariette,
• Jerome Avouac,
• Raphaele Seror,
• Gaetane Nocturne,
• Flore Rozenberg,
• Julien Henry,
• Rakiba Belkhir,
• Omar Al Tabaa,
• Roba Ghossan,
• Alice Andrée Mariaggi,
• Christelle Vauloup-Fellous

Affiliations

Samuel Bitoun

1 Department of Rheumatology, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, INSERM U1184, Le Kremlin Bicêtre, France

Xavier Mariette

Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux universitaires Paris-Sud – Hôpital Bicêtre, Le Kremlin Bicêtre, France

Jerome Avouac

Service de Rhumatologie, Hôpital Cochin, AP-HP.CUP, Universite de Paris, Paris, France

Raphaele Seror

Department of Rheumatology, Hôpital Bicêtre, Le Kremlin-Bicetre, France

Gaetane Nocturne

Department of Rheumatology, Hôpital Bicêtre, Le Kremlin-Bicetre, France

Flore Rozenberg

5 Université de Paris, Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Virologie, Paris, France

Julien Henry

Department of Rheumatology, AP-HP, Paris-Sud University Hospitals, Le Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France

Rakiba Belkhir

Rheumatology, Assistance Publique – Hôpitaux de Paris, Hospital Bicetre, Le Kremlin-Bicetre, France

Omar Al Tabaa

Rheumatology, Assistance Publique – Hôpitaux de Paris, Hospital Bicetre, Le Kremlin-Bicetre, France

Roba Ghossan

Rheumatology, Université Paris Cité Hôpital Cochin, AP-HP.CUP, Paris, France

Alice Andrée Mariaggi

Virology Department, Université Paris Cité, Hôpital Cochin, AP-HP.CUP, Paris, France

Christelle Vauloup-Fellous

Division of Virology, Department of Biology Genetics and PUI, Paris Saclay University Hospital, APHP, INSERM U1193, Université Paris Saclay, Villejuif, France